glp 1 and pulmonary embolism Add-on GLP-1 agonists in the treatment of intermediate risk acute embolism: a biomarker-driven proof-of-concept study Glucagon-like peptide-1 receptor analog use

Key Findings 93.4% of patients would get bariatric surgery again 51.4% of patients would consider using GLP-1 drugs again 57.1% of GLP-1 patients reported losing at least 20 pounds 98.1% of bariatric surgery patients reported losing at least 20 pounds Median weight loss for bariatric surgery patients was 100 pounds, as opposed to 20 for GLP-1s Average weight loss for bariatric surgery was reported to be 101.2, as opposed to 24.9 for GLP-1 users 93.4% of Patients Would Get Bariatric Surgery Again Out of all patients surveyed, 93.4% said they would get bariatric surgery again

Purge toxins, prevent the effects of aging, and grow healthier hair and skin

Hepatology 61: 870882, 2015

This is your program, your body, your choice

BPC-157 is a synthetic peptide derived from a natural compound found in the human stomach

Weight loss, when necessary, is critical to overall health, including sexual health